Taiwan

The hospital has achieved a 96.5% urgent test completion rate, 96.4% automatic report verification, reduced redraw rates, and a 5.6 sigma report accuracy.

It is actively involved in medical research and technological innovation.

The hospital’s innovative screening programme is saving lives through early detection.

It clinched the win for its digital transformation and biomedical innovations, and its CEO Der-Yang Cho for championing a patient-first approach.

It has set industry benchmarks for microbiome-based therapies in Taiwan, serving patients aged 3 to 99.

The exhibition will run from 5 June to 7.

The hospital expects to start treating patients in late 2028.

It will be launched in Q4 2025.

The centre focuses on cancer research, regenerative medicine, and AI-powered drug discovery.

The system uses multilingual voice recognition to accurately convert speech.

Both parties will also expand research and development efforts.

The systems will support projects involving multimodal large language models.

Discover how Taiwan's commitment to innovation is shaping the future of healthcare.

The platform utilises wearable devices and an AI model for accurate evaluation.

Scans are processed in a multi-axis imaging system X-ray machine for real-time output.

Two databases were utilised with more than 10,000 patients and over 10 years of tracking.